WallStreetZenWallStreetZen

NASDAQ: ADMA
Adma Biologics Inc Stock Ownership - Who owns Adma Biologics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Adma Biologics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Adam S. GrossmanPresident and CEO2025-10-246,000$16.00
$96.00kSell
Adam S. GrossmanPresident and CEO2025-10-2415,000$5.40
$81.00kBuy
Adam S. GrossmanPresident and CEO2025-10-2415,000$16.00
$240.00kSell
Adam S. GrossmanPresident and CEO2025-09-1515,000$5.40
$81.00kBuy
Adam S. GrossmanPresident and CEO2025-09-1515,000$16.13
$241.95kSell
Adam S. GrossmanPresident and CEO2025-09-156,000$16.13
$96.78kSell
Adam S. GrossmanPresident and CEO2025-08-1515,000$16.88
$253.20kSell
Adam S. GrossmanPresident and CEO2025-08-156,000$16.88
$101.28kSell
Adam S. GrossmanPresident and CEO2025-08-1515,000$5.40
$81.00kBuy
Kaitlin M. KestenbergmessinaCOO and SVP Compliance2025-07-301,208$18.59
$22.46kSell

1 of 7

ADMA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ADMA insiders and whales buy or sell their stock.

ADMA Shareholders

What type of owners hold Adma Biologics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc14.97%35,631,714$554.43MInstitution
Vanguard Group Inc8.81%20,974,996$326.37MInstitution
State Street Corp5.70%13,561,645$211.02MInstitution
Perceptive Advisors LLC5.57%13,262,375$206.36MInsider
Divestiture Trust Biotest5.41%12,886,740$200.52MInsider
Invesco Ltd5.25%12,505,478$194.59MInstitution
Ag Biotest4.25%10,109,534$157.30MInsider
Sachem Head Capital Management LP3.76%8,960,000$139.42MInstitution
Aisling Capital II LP2.58%6,136,998$95.49MInsider
Geode Capital Management LLC2.44%5,813,738$90.46MInstitution

1 of 3

ADMA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ADMA79.42%20.58%Net SellingNet Selling
CNTA90.05%9.95%Net SellingNet Selling
MIRM51.92%48.08%Net SellingNet Buying
SRRK62.11%37.89%Net SellingNet Buying
BLTE7.19%0.00%
View Top Biotech Stocks

Adma Biologics Stock Ownership FAQ

Who owns Adma Biologics?

Adma Biologics (NASDAQ: ADMA) is owned by 90.74% institutional shareholders, 23.51% Adma Biologics insiders, and 0.00% retail investors. Perceptive Advisors LLC is the largest individual Adma Biologics shareholder, owning 13.26M shares representing 5.57% of the company. Perceptive Advisors LLC's Adma Biologics shares are currently valued at $204.51M.

If you're new to stock investing, here's how to buy Adma Biologics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.